HIGHLIGHTS
- who: Mazen Almehmadi and collaborators from the Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, POBox, Taif, Saudi Arabia have published the research work: A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak, in the Journal: Viruses 2022, x of 13/07/2023
- what: Tecovirimat is a new hope against the MPX outbreak and biosecurity against smallpox or orthopoxvirus-related bioterrorism attacks.
- how: The overlapping results were removed and the summary of the finalized 12 studies is provided in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.